Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues

APMIS

Volumn 107, Issue 12, 1999, Pages 1101-1108

  Lee, Sug Hyung ^a   Shin, Min Sun ^a   Park, Won Sang ^a   Kim, Su Young ^a   Kim, Hong Sug ^a   Lee, Jong Heun ^a   Han, Seo Young ^a   Lee, Hun Kyung ^a   Park, Jik Young ^a   Oh, Ro Ra ^a   Jang, Ja June ^b   Lee, Jung Young ^a   Yoo, Nam Jin ^a  

^a The Catholic University of Korea   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Cancer; Fas; Fas associated phosphatase 1; Immunohistochemistry; Normal human tissues; Tissue distribution

Indexed keywords

FAS ANTIGEN; FAS ASSOCIATED PHOSPHATASE 1; PHOSPHATASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER TISSUE; COLON CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SARCOMA; STOMACH CARCINOMA; TISSUE DISTRIBUTION;

EID: 0033371285     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01515.x     Document Type: Article

References (28)

1. 1. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68: 251-306.
2. 2. Nagata S. Apoptosis by death factor. Cell 1997; 88:355-65.
3. 3. Trauth BC, Klas C, Peters AMJ, Matzku S, Moller P, Falk W, et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989;245:301-5.
4. 4. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989;169: 1747-56.
5. 5. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994;179:873-9.
6. 6. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-43.
7. 7. Leithäuser F, Dhein J, Mechtersheimer G, Koretz K, Brüderlein S, Henne C, et al. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 1993;69:415-29.
8. 8. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993;75:1169-78.
9. 9. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responses. Cancer Res 1994;54:1580-6.
10. 10. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 1994;263:1759-62.
11. 11. Sato T, Irie S, Kituda S, Reed JC. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 1995;268:411-5.
12. 12. Mori S, Murakami-Mori K, Jewett A, Nakamura S, Bonavida B. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis. Cancer Res 1996;56:1874-9.
13. 13. Yanagisawa J, Takahashi M, Kanki H, Yano-Yanagisawa H, Tazunoki T, Sawa E, et al. The molecular interaction of Fas and FAP-1. A tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J Biol Chem 1997;272:8539-45.
14. 14. Zhang X, Brunner T, Carter L, Button RW, Rogers P, Bradley L, et al. Unequal death in T helper cell Th1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 1997;185:1837-49.
15. 15. Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B, et al. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res 1998;58:1741-9.
16. 16. Itoh N, Tsujimoto Y, Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-7.
17. 17. Boise LH, Minn AJ, Noel PJ, June CH, Accavitti MA, Lindsten T, et al. CD28 costimulation can promote T- cell survival by enhancing the expression of Bcl-xL. Immunity 1995;3:87-98.
18. 18. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388:190-5.
19. 19. Itoh N, Nagata S. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J Biol Chem 1993; 268:10932-7.
20. 20. Saras J, Claesson-Welsh L, Heldin CH, Gonez LJ. Cloning and characterization of PTPL1, a protein tyrosine phosphatase with similarities to cytoskeletal-asssociated proteins. J Biol Chem 1994;269:24082-9.
21. 21. Eischen CM, Dick CJ, Leibson PJ. Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 1994; 153:1947-54.
22. 22. Maekawa K, Imagawa N, Nagamatsu M, Harada S. Molecular cloning of a novel protein-tyrosine phosphatase containing a membrane-binding domain and GLGF repeats. FEBS Lett 1994;337:200-6.
23. 23. Mller NPH, Mler KB, Lammer R, Kharitonenkov A, Sures I, Ullrich A. Src kinase associates with a member of a distinct subfamily of protein-tyrosine phosphatase containing an erzin-like domain. Proc Natl Acad Sci USA 1994;91:7477 81.
24. 24. Lee SH, Jang JJ, Lee JY, Kim SY, Park WS, Shin MS, et al. Fas ligand is expressed in normal skin and in some cutaneous malignancies. Br J Dermatol 1998;139:186-91.
25. 25. Merritt AJ, Potten CS, Kemp CJ, Hickman JA, Balmain A, Lane DP, et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 1994;54:614-7.
26. 26. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 1991;352:345-7.
27. 27. Hockenberry D, Nunez G, Milliman C, Screiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
28. 28. Komata Y, Inaba H, Zhou Y-W, Zhang X-L, Tanaka S, Azuma E, et al. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/ FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/ RIP) in human leukemia/ lymphoma cell lines. Br J Haematol 1997;99: 323-30.